Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (14538)	12/7/2004 2:56:28 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

I'm used to writing Antegren, so I'll probably just keep writing it.

To: rkrw who wrote (14538)	12/7/2004 3:48:41 PM
From: Biomaven	Respond to of 52153

If the pharmacists let us write ‘TD,’ I may do it. Chuckle. Well that's one illustration why Health Care Savings Accounts may actually work. Divorcing price totally from the consumption equation is always a bad idea. If the doctor knows that the patient is actually going to have to pay the extra bucks, maybe he or she would actually bother to write out "transdermal fentanyl." On the same theme, it "costs" a lot more (perhaps $1,500) to have a baby in one of Boston's teaching hospitals rather than in a community hospital. Right now a consumer doesn't see that extra cost. But under HCSA they would, and my guess is that a fair number might opt for their local community hospital. Of course the downside of HCSA is that consumers might end up neglecting medical conditions in order to save money. That simple facial boil that turns into orbital cellulitis or the strep throat that turns into rheumatic fever isn't going to save anyone any money. Peter